Intra-alveolar neutrophil-derived microvesicles predict development of primary graft dysfunction after lung transplantation.

S. Soni (London, United Kingdom), R. Romano (London, United Kingdom), K. O'Dea (London, United Kingdom), B. Patel (London, United Kingdom), K. Tatham (London, United Kingdom), M. Koh (London, United Kingdom), D. Tsiridou (London, United Kingdom), A. Simon (London, United Kingdom), L. Thakuria (London, United Kingdom), M. Wilson (London, United Kingdom), A. Reed (London, United Kingdom), N. Marczin (London, United Kingdom), M. Takata (London, United Kingdom)

Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Session: Treatments and biomarkers for lung allograft function and outcome
Session type: Oral Presentation
Number: 4726

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Soni (London, United Kingdom), R. Romano (London, United Kingdom), K. O'Dea (London, United Kingdom), B. Patel (London, United Kingdom), K. Tatham (London, United Kingdom), M. Koh (London, United Kingdom), D. Tsiridou (London, United Kingdom), A. Simon (London, United Kingdom), L. Thakuria (London, United Kingdom), M. Wilson (London, United Kingdom), A. Reed (London, United Kingdom), N. Marczin (London, United Kingdom), M. Takata (London, United Kingdom). Intra-alveolar neutrophil-derived microvesicles predict development of primary graft dysfunction after lung transplantation.. 4726

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012

Characterization of primary graft dysfunction after lung transplantation using 64-MSCT imaging
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Oxidized-polymers of Z-AT are associated with exaggerated pulmonary inflammation post lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


Are circulating progenitors involved in the repair of lung tissue?
Source: Annual Congress 2007 - Circulating progenitors as new actors in health and disease: angiogenesis and tissue repair
Year: 2007


A role for the mesothelium in restrictive chronic lung allograft dysfunction?
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017



B cells drive iBALT formation in a mouse model of chronic lung allograft dysfunction
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018

Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Lung volumes predict survival in patients with chronic lung allograft dysfunction
Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016
Year: 2017



Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure
Source: Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020
Year: 2021



The good and the bad of mesenchymal cells in chronic lung allograft dysfunction (CLAD)
Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation
Year: 2015



The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair
Source: Eur Respir J 2004; 24 : 664-673
Year: 2004



Inflammatory mediators associated with bone metabolism in patients awaiting lung transplantation
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012


Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019

Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

Lung transplantation for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 247-255
Year: 2012


Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Detection of late post stem cell transplantation lung function deterioration using simple spirometry.
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018